Dual-delivery of VEGF and PDGF by double-layered electrospun membranes for blood vessel regeneration

Biomaterials

Volumn 34, Issue 9, 2013, Pages 2202-2212

  Zhang, Hong ^a   Jia, Xiaoling ^b   Han, Fengxuan ^a   Zhao, Jin ^a   Zhao, Yunhui ^a   Fan, Yubo ^b   Yuan, Xiaoyan ^a  

^a TIANJIN UNIVERSITY   (China)

^b BEIHANG UNIVERSITY   (China)

Author keywords

Dual delivery; Electrospinning; Platelet derived growth factor; Small diameter vascular graft; Vascular endothelial growth factor

Indexed keywords

CAROTID ARTERY; CHITOSAN HYDROGEL; COAXIAL ELECTROSPINNING; DUAL DELIVERY; ELECTROSPUN MEMBRANES; ELECTROSPUNS; ENDOTHELIALIZATION; IN-VIVO; INNER LAYER; PLATELET-DERIVED GROWTH FACTORS; RELEASE PROFILES; RESTENOSIS; REVASCULARIZATION; VASCULAR ENDOTHELIAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR GRAFTS; VASCULAR SMOOTH MUSCLE CELLS;

CELL PROLIFERATION; DISEASES; ELECTROSPINNING; ENDOTHELIAL CELLS; ETHYLENE GLYCOL; GRAFTS; MEMBRANES; PLATELETS; TISSUE ENGINEERING;

BLOOD VESSELS;

CHITOSAN; MACROGOL; POLYCAPROLACTONE; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL GRAFT; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROSPINNING; EMULSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; BLOOD VESSELS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-SIS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ORYCTOLAGUS CUNICULUS;

EID: 84872399600     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.12.005     Document Type: Article

References (39)

1. Cancedda R., Dozin B., Giannoni P., Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003, 22:81-91.
2. Cao Y., Croll T.I., Lees J.G., Tuch B.E., Cooper-White J.J. Scaffolds, stem cells, and tissue engineering: a potent combination!. Aust J Chem 2005, 58:691-703.
3. Pham Q.P., Sharma U., Mikos A.G. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng 2006, 12:1197-1211.
4. Sill T.J., von Recum H.A. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 2008, 29:1989-2006.
5. Lee S.J., Liu J., Oh S.H., Soker S., Atala A., Yoo J.J. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 2008, 29:2891-2898.
6. Sell S.A., McClure M.J., Garg K., Wolfe P.S., Bowlin G.L. Electrospinning of collagen/biopolymers for regenerative medicine and cardiovascular tissue engineering. Adv Drug Deliv Rev 2009, 61:1007-1019.
7. Hong Y., Ye S.H., Nieponice A., Soletti L., Vorp D.A., Wagner W.R. A small diameter, fibrous vascular conduit generated from a poly(ester urethane) urea and phospholipid polymer blend. Biomaterials 2009, 30:2457-2467.
8. Zheng W.T., Wang Z.H., Song L.J., Zhao Q., Zhang J., Li D., et al. Endotelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. Biomaterials 2012, 33:2880-2891.
9. Jia X.L., Zhao C.G., Li P., Zhang H., Huang Y., Li H., et al. Sustained release of VEGF by coaxial electrospun dextran/PLGA fibrous membranes in vascular tissue engineering. J Biomat Sci-Polym E 2011, 22:1811-1827.
10. Li X.Q., Su Y., Zhou X., Mo X.M. Distribution of Sorbitan Monooleate in poly(l-lactide-co-ε-caprolactone) nanofibers from emulsion electrospinning. Colloid Surf B 2009, 69:221-224.
11. Jiang H.L., Hu Y.Q., Li Y., Zhao P.C., Zhu K.J., Chen W. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Control Release 2005, 108:237-243.
12. Baguneid M.S., Seifalian A.M., Salacinski H.J., Murray D., Hamilton G., Walker M.G. Tissue engineering of blood vessels. Br J Surg 2006, 93:282-290.
13. Du F.Y., Wang H., Zhao W., Li D., Kong D.L., Yang J., et al. Gradient nanofibrous chitosan/poly ε-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering. Biomaterials 2012, 33:762-770.
14. Janairo R.R.R., Henry J.J.D., Lee B.L.P., Hashi C.K., Derugin N., Lee R., et al. Heparin-modified small-diameter nanofibrous vascular grafts. IEEE T Nanobiosci 2012, 11:22-27.
15. Browning M.B., Dempsey D., Guiza V., Becerra S., Rivera J., Russell B., et al. Multilayer vascular grafts based on collagen-mimetic proteins. Acta Biomater 2012, 8:1010-1021.
16. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19:1029-1034.
17. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
18. Conway E.M., Collen D., Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001, 49:507-521.
19. Ozawa C.R., Banfi A., Nicole L., Glazer N.L., Thurston G., Springer M.L., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004, 113:516-527.
20. Benjamin L.E., Hemo I., Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998, 125:1591-1598.
21. Grant D.S., Kleinman H.K., Goldberg I.D. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A 1993, 90:1937-1941.
22. Chen R.R., Silva E.A., Yuen W.W., Mooney D.J. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 2007, 24:258-264.
23. Dorafshar A.H., Angle N., Bryer-Ash M., Huang D.S., Farooq M.M., Gelabert H.A., et al. Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation. J Surg Res 2003, 114:179-186.
24. Yoshikawa Y., Abrahamsson S.O. Dose related cellular effects of platelet-derived growth factor-BB differ in various types of rabbit tendons in vitro. Acta Orthop Scand 2001, 72:287-292.
25. Chen F.M., Zhang M., Wu Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31:6279-6308.
26. Sun H.H., Qu T.J., Zhang X.H., Yu Q., Chen F.M. Designing biomaterials for in situ periodontal tissue regeneration. Biotechnol Prog 2012, 28:3-20.
27. Place E.S., Evans N.D., Stevens M.M. Complexity in biomaterials for tissue engineering. Nat Mater 2009, 8:457-470.
28. Matsui M., Tabata Y. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater 2012, 8:1792-1801.
29. Montero R.B., Vial X., Nguyen D.T., Farhand S., Reardon M., Pham S.M., et al. bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis. Acta Biomater 2012, 8:1778-1791.
30. Ekaputra A.K., Prestwich G.D., Cool S.M., Hutmacher D.W. The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly(ε-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials 2011, 32:8108-8117.
31. 165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 2007, 75:178-185.
32. Li H., Zhao C.G., Wang Z.X., Zhang H., Yuan X.Y., Kong D.L. Controlled release of PDGF-bb by coaxial electrospun dextran/poly(l-lactide-co-ε-caprolactone) fibers with an ultrafine core/shell structure. J Biomat Sci-Polym E 2010, 21:803-819.
33. Zhang H., Zhao Y.H., Han F.X., Wang M., Yuan X.Y. Controlled release of bovine serum albumin from electrospun fibrous membranes via an improved emulsion-core technique. J Control Release 2011, 152(S1):e181-e182.
34. Go D.H., Joung Y.K., Park S.Y. Heparin-conjugated star-shaped PLA for improved biocompatibility. J Biomed Mater Res A 2008, 86A:842-848.
35. Zhang H., Zhao C.G., Zhao Y.H., Tang G.W., Yuan X.Y. Electrospinning of ultrafine core/shell fibers for biomedical applications. Sci China Chem 2010, 53:1246-1254.
36. Soslow R.A., Dannenberg A.J., Rush D., Woerner B.M., Khan N.K., Masferrer J., et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000, 89:2637-2645.
37. Remmele W., Schicketanz K.H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 1993, 8:227-245.
38. Pike D.B., Cai S., Pomraning K.R., Firpo M.A., Fisher R.J., Shu X.Z., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27:5242-5251.
39. Schumann D.A., Wippermann J., Klemm D.O., Kramer F., Koth D., Kosmehl D., et al. Artificial vascular implants from bacterial cellulose: preliminary results of small arterial substitutes. Cellulose 2009, 16:877-885.